Riskpilot← Back to searchSign inGet full accessMedical SWE AB
ABActiveOrg 5591460471Karlbergsvägen 22General medical practice activities · NACE 8621Est. 201810-19 employees
Revenue 2024
SEK 13,6M
+31% vs 2023
EBITDA margin
7.3%
+11% vs 2023
Equity ratio
65.9%
Financial strength
Net profit 2024
SEK 723K
+22% vs 2023
| Revenue | SEK 13,6M | +31% |
| EBITDA | SEK 995K | +11% |
| Net profit | SEK 723K | +22% |
| Total assets | SEK 3,7M | -3% |
| Equity | SEK 2,5M | +27% |
| Employees | — | — |
Legal name
Medical SWE AB
Org number
5591460471
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
22 januari 2018
Share capital
SEK 50 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Avser bedriva verksamhet inom hälso och sjukvård, estetik, kirurgi, tandvård, konsulttjänster inom tandvård samt hälso och sjukvård äga och förvalta fast eller lös egendom samt i övrigt bedriva med dessa rörelsegrenar förenlig verksamhet.
Address
Karlbergsvägen 22
Email
dms_ax@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 670 | 4 727 | 3 456 | 10 427 | 13 628 |
| Staff expenses | — | — | −1 514 | — | −7 542 |
| EBITDA | 374 | 1 661 | −491 | 899 | 995 |
| Depreciation & amort. | −166 | −279 | −296 | −181 | −103 |
| EBIT | 208 | 1 382 | −788 | 718 | 892 |
| Net financials | — | — | 0 | 9 | 31 |
| Profit before tax | 156 | 1 383 | −183 | 728 | 923 |
| Tax | −33 | −286 | — | −138 | −200 |
| Net profit | 123 | 1 097 | −183 | 590 | 723 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 663 | 3 831 | 2 003 | 3 865 | 3 736 |
| Equity | 724 | 1 820 | 1 450 | 1 940 | 2 462 |
| Long-term debt | 0 | 0 | — | 0 | — |
| Short-term debt | 334 | 1 406 | 553 | 1 925 | 1 274 |
| Total debt | 334 | 1 406 | 553 | 1 925 | 1 274 |
EBITDA margin
7.3%
This company
15.8%
Market median
-54% vs market
20202024
Equity ratio
65.9%
This company
38.2%
Market median
+73% vs market
20202024
Return on equity
29.4%
This company
18.4%
Market median
+60% vs market
20202024
Net profit margin
5.3%
This company
8.1%
Market median
-35% vs market
20202024
Asset turnover
3.65×
This company
1.12×
Market median
+226% vs market
20202024
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JS Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medical SWE AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Sebastian Hansson | Chief Auditor | 0 companies |
| Dariush Alexander Daniel Maksoutov | Board of Directors | 0 companies |
| Eleonor Nailia Sandbu | Deputy Board Member | 0 companies |